The primary objective of this study is to establish an IL-6 concentration cutoff and optimal time point(s) for using Symphony IL-6 that predict 28-day mortality in patients who are admitted or are intended to be admitted to the intensive care unit (ICU) diagnosed with sepsis or septic shock.
Study Type
OBSERVATIONAL
Enrollment
143
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Washington University of St. Louis
St Louis, Missouri, United States
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
28-day all-cause mortality
Participants will be followed up for 28 days for all-cause mortality
Time frame: Within 28 days after inclusion
In-hospital mortality up to 28 days
Participants will be followed up for 28 days for in-hospital mortality
Time frame: Within 28 days after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Ohio State University/Wexner Medical Center
Columbus, Ohio, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Intermountain Healthcare
Salt Lake City, Utah, United States